EUVIMEDEUVIMED entdecken
Crossref

Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD

Shea E Hogan iD, Eike Sebastian Debus, Mark R Nehler, Manesh R Patel iD, Sonia S Anand iD, Eva Muehlhofer iD, Lloyd P Haskell iD, Scott D Berkowitz iD, Rupert M Bauersachs iD, Marc P Bonaca iD

Circulation · 2024

DOI: 10.1161/circulationaha.123.065330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2024. Verfasst von Shea E Hogan und 9 weiteren Autor:innen. Beteiligte Einrichtung: CPC Clinical Research, Aurora, CO (S.E.H., M.R.N., S.D.B., M.P.B.). Hauptthemen laut MEDLINE: Chronic Limb-Threatening Ischemia, Endovascular Procedures, Rivaroxaban, Vascular Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic Limb-Threatening IschemiaEndovascular ProceduresRivaroxabanVascular Surgical ProceduresHumansIschemiaLimb SalvageLower ExtremityPeripheral Arterial DiseaseRisk FactorsTreatment OutcomeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

chronic limb-threatening ischemiaendovascular proceduresischemiaperipheral arterial diseaserivaroxabanvascular surgical procedures

Substanzen

Rivaroxaban

Autor:innen und Institutionen

  • CPC Clinical Research, Aurora, CO (S.E.H., M.R.N., S.D.B., M.P.B.).
  • Denver Health, CO (S.E.H.).
  • Department of Medicine, University of Colorado, Aurora (S.E.H., S.D.B., M.P.B.).
  • University Heart & Vascular Center Hamburg-Eppendorf, Hamburg, Germany (E.S.D.).
  • Department of Surgery, University of Colorado, Aurora (M.R.N.).
  • Duke Clinical Research Institute, Duke University, Durham, NC (M.R.P.).

ORCID-Profile: Shea E Hogan, Manesh R Patel, Sonia S Anand, Eva Muehlhofer, Lloyd P Haskell, Scott D Berkowitz, Rupert M Bauersachs, Marc P Bonaca

Zitieren

APA

Hogan, S. E., Debus, E. S., Nehler, M. R., Patel, M. R., Anand, S. S., Muehlhofer, E., Haskell, L. P., Berkowitz, S. D., Bauersachs, R. M., & Bonaca, M. P. (2024). Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation. https://doi.org/10.1161/circulationaha.123.065330

Vancouver

Hogan SE, Debus ES, Nehler MR, Patel MR, Anand SS, Muehlhofer E, et al. Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD. Circulation. 2024. doi:10.1161/circulationaha.123.065330

BibTeX
@article{Hogan2024,
  author = {Hogan, Shea E and Debus, Eike Sebastian and Nehler, Mark R and Patel, Manesh R and Anand, Sonia S and Muehlhofer, Eva and Haskell, Lloyd P and Berkowitz, Scott D and Bauersachs, Rupert M and Bonaca, Marc P},
  title = {Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.123.065330}
}
Kostenlos starten →